Rethinking type 2 diabetes: a bone marrow disease under metabolic disguise?
Type 2 diabetes (T2D) is traditionally viewed as a metabolic disorder driven by insulin resistance and progressive pancreatic β-cell failure. This review examines how metabolic stress remodels the bone marrow (BM) niche and whether these alterations contribute to inflammatory haematopoiesis, defective vascular repair and disease progression. The BM niche is a specialized microenvironment integrating endothelial, mesenchymal, neural, adipocytic, and immune components that cooperatively regulate hematopoietic stem and progenitor cell (HSPC) maintenance, mobilization and immune homeostasis. Evidence from animal models, together with more limited human observations, indicates that obesity-associated inflammation, lipotoxicity and hyperglycaemia can alter these compartments, favour myeloid-biased haematopoiesis and induce persistent metabolic and epigenetic reprogramming. The resulting inflammatory myeloid output may subsequently amplify adipose-tissue and pancreatic islet inflammation, while vascular and autonomic niche dysfunction may constrain endogenous repair, creating bidirectional feedback between systemic metabolic dysfunction and the BM. We integrate these processes within diabet(ogen)ic nicheopathy , a proposed research framework encompassing BM alterations that may arise from and potentially reinforce metabolic disease. Particular attention is given to BM adipose tissue, BM–pancreas inflammatory crosstalk, progenitor mobilopathy and the therapeutic implications of BM programming. However, whether BM alterations precede overt T2D, contribute independently to its progression or predominantly reflect cumulative metabolic injury remains unresolved. The BM niche should therefore be regarded as an emerging mechanistic and therapeutic target rather than an established determinant of T2D progression.
Authors
- Riccardo C. Bonadonna (ORCID: https://orcid.org/0000-0002-9809-1005)
- Francesca Coppi (ORCID: https://orcid.org/0000-0001-7715-6941)
- Valentina Spigoni (ORCID: https://orcid.org/0000-0001-5716-1671)
- Barbara Altieri (ORCID: https://orcid.org/0000-0003-2616-3249)
- Maddalena Trombetta (ORCID: https://orcid.org/0000-0002-0825-1117)
- Federica Fantuzzi (ORCID: https://orcid.org/0000-0003-3202-3947)
- Alessandra Dei (ORCID: https://orcid.org/0000-0002-8666-4849)
- Lorenzo Taglia (ORCID: https://orcid.org/0009-0006-8027-4520)
- Elisabetta Giordano (ORCID: https://orcid.org/0009-0009-9644-8021)
Institutions
- University of Verona (IT)
- University of Modena and Reggio Emilia (IT)
- University of Parma (IT)
- Ospedale di Parma (IT)
Publication Details
- Journal
- Reviews in Endocrine and Metabolic Disorders
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s11154-026-10105-x
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00